Smith Douglas Homes Corp. (SDHC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Smith Douglas Homes Corp. (SDHC) reported $223.92 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 1.4%. EPS of -$0.13 for the same period compares to $0.40 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $216.52 million, representing a surprise of +3.42%. The company delivered an EPS surprise of -152%, with the consensus EPS estimate being $0.25.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Smith Douglas Homes Corp. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Net new home orders: 736 versus the two-analyst average estimate of 757.Backlog homes (period end): 858 versus 904 estimated by two analysts on average.Home closings: 669 versus 644 estimated by two analysts on average.Active communities (period end): 92 compared to the 89 average estimate based on two analysts.ASP of homes closed: $335 million versus the two-analyst average estimate of $336.31 million.View all Key Company Metrics for Smith Douglas Homes Corp. here>>>Shares of Smith Douglas Homes Corp. have returned +1.3% over the past month versus the Zacks S&P 500 composite's +0.5% change. The stock currently has a Zacks Rank #5 (Strong Sell), indicating that it could underperform the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Smith Douglas Homes Corp. (SDHC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks